Development of a questionnaire to measure patient-relevant needs and benefits in the treatment of epilepsy (PBI-Epilepsy)

被引:0
|
作者
Janke, Toni Maria [1 ]
Cuny, Jeanne [2 ]
Blome, Christine [1 ]
Wittig-Mossner, Doris [3 ]
Hamer, Hajo [2 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, Martinistr 52, D-20246 Hamburg, Germany
[2] Univ Hosp Erlangen, Epilepsy Ctr, Dept Neurol, Erlangen, Germany
[3] Bavarian Epilepsy Assoc, Nurnberg, Germany
关键词
Patient benefit; Patient benefit index; PBI; Patient-reported outcome; Questionnaire development; QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; PEOPLE; VALIDATION; OUTCOMES; INSTRUMENT; ADULTS; COSTS;
D O I
10.1016/j.yebeh.2024.110152
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objective: Therapeutic goals in epilepsy treatment may be highly individual. The aim of the present study was to develop a questionnaire assessing patients' needs and benefits of epilepsy treatment, the Patient Benefit Index on Epilepsy (PBI-Epilepsy). Methods: We recruited adult patients during their stay at a university based epilepsy centre. Patients completed a survey asking about their burden and treatment goals. Data were categorised using qualitative content analysis. The final category system was discussed in an expert panel. The questionnaire was pre-tested using cognitive debriefing and adapted until no changes were required anymore. Results: In the open survey, 25 people with epilepsy participated (60.0 % female, 33.2 years, 1-55 years epilepsy). The final category system included nine main categories (namely psyche, working life, seizures, therapy, leisure activities, social relationships, mobility, body, everyday life activities). From this, the expert panel developed a first draft of the PBI-Epilepsy. The questionnaire went through five rounds of cognitive debriefing with 29 patients (51.7 % female, 34.6 years, 2-37 years epilepsy). We decided to develop two versions of the questionnaire depending on the patient's treatment (medical or surgical). A bipolar response scale was used in the part asking about treatment benefits, as epilepsy treatment can lead to both improvement and deterioration. The final questionnaire consists of two parts (patient needs and treatment benefits) each encompassing 21 items. Conclusion: We aimed to reflect the wide range of issues that are relevant for people with epilepsy while developing a questionnaire that is short and easy for patients to understand.
引用
收藏
页数:7
相关论文
共 47 条
  • [1] Patient-relevant therapy goals and benefits in the treatment of epilepsy
    Klein, Toni Maria
    Blome, Christine
    Westermayer, Vivien
    Cuny, Jeanne
    Hamer, Hajo M.
    QUALITY OF LIFE RESEARCH, 2021, 30 (SUPPL 1) : S154 - S155
  • [2] Development and Pilot Validation of a Questionnaire on patient-relevant Goals and Benefits in topical Therapy for Psoriasis (PBI-TOP)
    Blome, Christine
    Huelswitt, Lennart
    Meineke, Anna
    Augustin, Matthias
    Ohm, Frenz
    Rusch, Judith
    Janke, Toni Maria
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 96 - 96
  • [3] Validation of the Patient Benefit Index for Psoriatic Arthritis (PBI-PsA) to Measure the patient-relevant Treatment Goals and Benefits
    Blome, Christine
    Fedel, Helen
    Meineke, Anna
    Ben-Anaya, Nesrine
    Kirsten, Natalia
    Augustin, Matthias
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 85 - 86
  • [4] Patient-relevant needs and treatment goals in nail psoriasis
    C. Blome
    A. Costanzo
    E. Dauden
    C. Ferrandiz
    G. Girolomoni
    R. Gniadecki
    L. Iversen
    A. Menter
    K. Michaelis-Wittern
    A. Morita
    H. Nakagawa
    K. Reich
    M. Augustin
    Quality of Life Research, 2016, 25 : 1179 - 1188
  • [5] Patient-relevant needs and treatment goals in nail psoriasis
    Blome, C.
    Costanzo, A.
    Dauden, E.
    Ferrandiz, C.
    Girolomoni, G.
    Gniadecki, R.
    Iversen, L.
    Menter, A.
    Michaelis-Wittern, K.
    Morita, A.
    Nakagawa, H.
    Reich, K.
    Augustin, M.
    QUALITY OF LIFE RESEARCH, 2016, 25 (05) : 1179 - 1188
  • [6] Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool
    Blome, C.
    Augustin, M.
    Siepmann, D.
    Phan, N. Q.
    Rustenbach, S. J.
    Staender, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1143 - 1148
  • [7] MEASURING PATIENT-RELEVANT TREATMENT BENEFIT IN DERMATOLOGY - DEVELOPMENT AND VALIDATION OF THE SHORT QUESTIONNAIRE "PATIENT BENEFIT INDEX 2.0"
    Blome, C.
    von Usslar, K.
    Augustin, M.
    VALUE IN HEALTH, 2013, 16 (07) : A330 - A330
  • [8] Development and Validation of the Patient Benefit Index (PBI) to assess Patient Needs and Benefits in Rosacea-Treatment
    Augustin, M.
    Sommer, R.
    A, Koerber
    Blome, C.
    Kirsten, N.
    Maul, J-T
    Langenbruch, A. K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 190 - 190
  • [9] The "Patient Benefit Index 2.0" - A short Questionnaire for a Survey of Patient-relevant Treatment Benefit in Dermatology
    Blome, C.
    von Usslar, K.
    Augustin, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 92 - 92
  • [10] Patient-relevant, rather than physician-friendly, definitions of disease: An improved definition of epilepsy
    Weaver, DF
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (07): : 805 - 806